Discovery of novel and potent InhA inhibitors by an in silico screening and pharmacokinetic prediction

Future Med Chem. 2022 May;14(10):717-729. doi: 10.4155/fmc-2021-0348. Epub 2022 Apr 29.

Abstract

Aim: In silico screening approaches were performed to discover novel InhA inhibitors. Methods: Candidate InhA inhibitors were obtained from the combination of virtual screening and pharmacokinetic prediction. In addition, molecular mechanics Poisson-Boltzmann surface area, molecular mechanics Generalized Born surface area and WaterSwap methods were performed to investigate the binding interactions and binding energy of candidate compounds. Results: Four candidate compounds with suitable physicochemical, pharmacokinetic and antibacterial properties are proposed. The crucial interactions of the candidate compounds were H-bond, pi-pi and sigma-pi interactions observed in the InhA binding site. The binding affinity of these compounds was improved by hydrophobic interactions with hydrophobic side chains in the InhA pocket. Conclusion: The four newly identified InhA inhibitors reported in this study could serve as promising hit compounds against Mycobacterium tuberculosis and may be considered for further experimental studies.

Keywords: InhA inhibitor; MM-GBSA; MM-PBSA; Mycobacterium tuberculosis; WaterSwap; antibacterial prediction; glide docking; virtual screening.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents* / chemistry
  • Antitubercular Agents* / pharmacology
  • Bacterial Proteins / chemistry
  • Binding Sites
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Mycobacterium tuberculosis*

Substances

  • Antitubercular Agents
  • Bacterial Proteins